Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women

American Journal of Obstetrics and Gynecology

Volumn 173, Issue 5, 1995, Pages 1446-1451

  Dören, Martina ^a   Reuther, Gerd ^a   Minne, Helmut W ^a   Schneider, Hermann P G ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

compliance of estrogen replacement therapy; Continuously combined estrogen progestogen replacement therapy; sequential estrogen progestogen replacement

Indexed keywords

ESTRADIOL VALERATE; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ACETATE;

ADULT; AMENORRHEA; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MINERAL; CLIMACTERIUM; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 0028849690     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9378(95)90631-2     Document Type: Article

References (17)

1. Enhancing patient compliance with hormone replacement therapy at menopause
2. Precise measurement of vertebral mineral content using computed tomography
3. Endometrial histology and bleeding patterns after 8 years of continuous combined estrogen and progestogen therapy in postmenopausal women
4. The “Red Queen” and endometrial hyperplasia [Letter]
5. Continuous combined hormone replacement therapy and the risk of endometrial cancer—preliminary report
6. Continuous oestrogen-progestogen treatment and serum lipoproteins in postmenopausal women
7. Use of estrogens among middle-aged Massachusetts women
8. Compliance difficulties with progestin supplemented replacement therapy
9. Results of bone densitometry affect women's decisions about taking measures to prevent fractures
10. Bone loss during oestriol therapy in postmenopausal women
11. Prevention of bone mineral loss in postmenopausal women by norethisterone
12. Reversal of postmenopausal vertebral bone loss by oestrogen and progestogen: a double blind placebo controlled study
13. Continuous oestrogen-progestogen treatment and bone metabolism in postmenopausal women
14. Five years with continuous combined oestrogen/progestogen therapy: effects on calcium metabolism, lipoproteins, and bleeding pattern
15. Four years of continuous and sequential estrogen/progestin administration on lumbar spine density
16. Assessment of bone mass